ABM Knowledgeware Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 14, 2025, 10:07 pm

Quick Insight

ABM Knowledgeware Ltd, operating in the IT Consulting & Software industry, currently trades at a price of 169 with a market capitalization of 338 Cr. The company's P/E ratio stands at 20.9, indicating a reasonable valuation, while ROE and ROCE are at 6.78% and 8.62% respectively, reflecting moderate returns on equity and capital employed. With a healthy operating profit margin of 14.43% and a strong interest coverage ratio of 94.43x, ABM shows operational efficiency and robust financial health. The high promoter holding of 66.93% underscores confidence in the business. However, the lower FII and DII holdings may suggest room for increased institutional investment, potentially driving future growth and market interest in the stock.

Competitors of ABM Knowledgeware Ltd

All Competitor Stocks of ABM Knowledgeware Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:40 am

Below is a detailed analysis of the quarterly data for ABM Knowledgeware Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 20.16 Cr.. The value appears to be declining and may need further review. It has decreased from 21.51 Cr. (Mar 2025) to 20.16 Cr., marking a decrease of 1.35 Cr..
• For Expenses, as of Jun 2025, the value is 17.25 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.01 Cr. (Mar 2025) to 17.25 Cr., marking a decrease of 0.76 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.91 Cr.. The value appears to be declining and may need further review. It has decreased from 3.50 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.59 Cr..
• For OPM %, as of Jun 2025, the value is 14.43%. The value appears to be declining and may need further review. It has decreased from 16.27% (Mar 2025) to 14.43%, marking a decrease of 1.84%.
• For Other Income, as of Jun 2025, the value is 2.67 Cr.. The value appears strong and on an upward trend. It has increased from 2.54 Cr. (Mar 2025) to 2.67 Cr., marking an increase of 0.13 Cr..
• For Interest, as of Jun 2025, the value is 0.07 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.07 Cr..
• For Depreciation, as of Jun 2025, the value is 0.29 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.29 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.22 Cr.. The value appears to be declining and may need further review. It has decreased from 5.68 Cr. (Mar 2025) to 5.22 Cr., marking a decrease of 0.46 Cr..
• For Tax %, as of Jun 2025, the value is 19.54%. The value appears to be improving (decreasing) as expected. It has decreased from 21.30% (Mar 2025) to 19.54%, marking a decrease of 1.76%.
• For Net Profit, as of Jun 2025, the value is 4.20 Cr.. The value appears to be declining and may need further review. It has decreased from 4.48 Cr. (Mar 2025) to 4.20 Cr., marking a decrease of 0.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.10. The value appears to be declining and may need further review. It has decreased from 2.24 (Mar 2025) to 2.10, marking a decrease of 0.14.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:40 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:00 pm

Below is a detailed analysis of the balance sheet data for ABM Knowledgeware Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 225.00 Cr.. The value appears strong and on an upward trend. It has increased from 212.00 Cr. (Mar 2024) to 225.00 Cr., marking an increase of 13.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2024) to 34.00 Cr., marking an increase of 3.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 270.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 253.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 17.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 42.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 42.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 17.00 Cr..
• For Other Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2024) to 99.00 Cr., marking a decrease of 1.00 Cr..
• For Total Assets, as of Mar 2025, the value is 270.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Mar 2024) to 270.00 Cr., marking an increase of 17.00 Cr..

Notably, the Reserves (225.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for ABM Knowledgeware Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.26. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.26, marking an increase of 0.08.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.26. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.26, marking an increase of 0.08.
• For Cash EPS (Rs.), as of Mar 25, the value is 11.11. This value is within the healthy range. It has increased from 9.43 (Mar 24) to 11.11, marking an increase of 1.68.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.53. It has increased from 110.39 (Mar 24) to 114.53, marking an increase of 4.14.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.53. It has increased from 110.39 (Mar 24) to 114.53, marking an increase of 4.14.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 47.19. It has increased from 44.50 (Mar 24) to 47.19, marking an increase of 2.69.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.69. This value is within the healthy range. It has increased from 11.73 (Mar 24) to 13.69, marking an increase of 1.96.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.87. This value is within the healthy range. It has increased from 10.09 (Mar 24) to 11.87, marking an increase of 1.78.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 9.96 (Mar 24) to 11.73, marking an increase of 1.77.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 9.30. This value is within the healthy range. It has increased from 7.78 (Mar 24) to 9.30, marking an increase of 1.52.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.02. This value is within the healthy range. It has decreased from 7.07 (Mar 24) to 7.02, marking a decrease of 0.05.
• For PBDIT Margin (%), as of Mar 25, the value is 29.00. This value is within the healthy range. It has increased from 26.36 (Mar 24) to 29.00, marking an increase of 2.64.
• For PBIT Margin (%), as of Mar 25, the value is 25.15. This value exceeds the healthy maximum of 20. It has increased from 22.66 (Mar 24) to 25.15, marking an increase of 2.49.
• For PBT Margin (%), as of Mar 25, the value is 24.84. This value is within the healthy range. It has increased from 22.38 (Mar 24) to 24.84, marking an increase of 2.46.
• For Net Profit Margin (%), as of Mar 25, the value is 19.69. This value exceeds the healthy maximum of 10. It has increased from 17.49 (Mar 24) to 19.69, marking an increase of 2.20.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.88. This value is within the healthy range. It has decreased from 15.88 (Mar 24) to 14.88, marking a decrease of 1.00.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 15. It has decreased from 6.50 (Mar 24) to 6.13, marking a decrease of 0.37.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 8.68 (Mar 24) to 9.65, marking an increase of 0.97.
• For Return On Assets (%), as of Mar 25, the value is 5.12. This value is within the healthy range. It has decreased from 5.53 (Mar 24) to 5.12, marking a decrease of 0.41.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.35. There is no change compared to the previous period (Mar 24) which recorded 0.35.
• For Current Ratio (X), as of Mar 25, the value is 6.48. This value exceeds the healthy maximum of 3. It has decreased from 7.49 (Mar 24) to 6.48, marking a decrease of 1.01.
• For Quick Ratio (X), as of Mar 25, the value is 6.48. This value exceeds the healthy maximum of 2. It has decreased from 7.49 (Mar 24) to 6.48, marking a decrease of 1.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 17.26 (Mar 24) to 0.00, marking a decrease of 17.26.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.00 (Mar 24) to 0.00, marking a decrease of 14.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 82.74 (Mar 24) to 0.00, marking a decrease of 82.74.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 86.00 (Mar 24) to 0.00, marking a decrease of 86.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 94.43. This value is within the healthy range. It has increased from 93.26 (Mar 24) to 94.43, marking an increase of 1.17.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 65.13. This value is within the healthy range. It has increased from 62.87 (Mar 24) to 65.13, marking an increase of 2.26.
• For Enterprise Value (Cr.), as of Mar 25, the value is 307.08. It has increased from 191.33 (Mar 24) to 307.08, marking an increase of 115.75.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.18. This value exceeds the healthy maximum of 3. It has increased from 2.10 (Mar 24) to 3.18, marking an increase of 1.08.
• For EV / EBITDA (X), as of Mar 25, the value is 10.95. This value is within the healthy range. It has increased from 7.96 (Mar 24) to 10.95, marking an increase of 2.99.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has increased from 2.25 (Mar 24) to 3.40, marking an increase of 1.15.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 82.73 (Mar 24) to 0.00, marking a decrease of 82.73.
• For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 0.91 (Mar 24) to 1.40, marking an increase of 0.49.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has increased from 2.25 (Mar 24) to 3.40, marking an increase of 1.15.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.04, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness